Zota Healthcare Ltd. Company History and Annual Growth Details

The Company was incorporated as "Zota Health Care Private Limited" at Surat, Gujarat as a Private Limited Company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated July 12, 2000 bearing Registration Number 04-38352 issued by Assistant Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Subsequently, the Company was converted into Public Company pursuant to Shareholders resolution passed at the Extraordinary General Meeting of the Company held on July 28, 2008 and the name of the Company was changed to "Zota Health Care Limited" and a Fresh Certificate of Incorporation Consequent upon Conversion from Private Company to Public Company dated August 18, 2008 was issued by the Assistant Registrar of Companies, Gujarat, Dadra and Nagar Haveli. The Corporate Identification Number of the Company is U24231GJ2000PLC038352. Ketankumar Zota, Manukant Zota, Himanshu Zota and Kamlesh Zota are the promoters of the Company and initial subscribers to the Memorandum of Association. We are a pharmaceutical based company, engaged in developing, manufacturing and marketing a broad range of pharmaceutical products. We mainly develop and market segregated pharmaceutical products, which we commercialize through the network of the distributor channel for the domestic sales. the Company has been certified as ISO-9001:2008 and have modern plant, equipmentÂs, with necessary restheces. For information on the CompanyÂs profile, activities, market, products, etc., market of each segment, capacity built-up, exports due to foreign operations together with country wise analysis, standing of the Company in comparison with prominent competitors, with reference to its products, management, managerial competence, technology, market, major suppliers and customers, environmental issues, geographical segment, etc.

KEY EVENTS AND MILESTONES :

The following table sets forth the key events and milestones in the history of the Company, since incorporation:

2000

-Incorporated as a Private Limited Company

2004

-Acquired all Brand names of Sayona Medicare Pvt. Ltd through MOU

2007

-Acquired Trade Mark and Brand Name of Mexon Healthcare Limited including, its two divisions Health Park Laboratories and Aaron Biotech

2008

-Conversion into Public Limited Company

2009

-Patent Received for "Pharmaceutical Compositions containing Taurine and Race- Methionine for the Treatment of Alcoholism"

2010

-Acquired Trademark Rights and Good will of Zota Pharmaceuticals and A TO Z pharmaceuticals

-Export oriented speciality manufacturing unit was inaugurated in Sursez to cater worldwide needs of medicines

-Patent Received for "An Antioxidants Granule Compositin"

-Patent Received for "A Formulation to Reduce Inflammation of Bones and Joint Friction"

-Patent Received for "Anti Inflammatory Composition"

-Patent Received for "A Pharmaceutical Oral Formulation"

2011

-Patent Received for "Novel Oral Pharmaceutical composition for the treatment of Respiratory Allergic Disease

-Acquired Trade Mark, Brand Names, Franchise, Marketing Network, etc. of Vision Medilinks to cater further growth

-Expanded its business beyond the geographical boundaries of India and started trading and dealing with African countries

2012

-Selected for European Patent Survey Office for a survey amongst 800 global pharmaceutical aspirants.

-Manufacturing plant in Sursez got WHO-GMP approval.

2013

-Acquired Trade Mark, Brand Names, Franchise, Marketing Network, etc Secure Healthcare Inc and Effect Biotech Inc

-Nominated for "CNBC-TV-18 Emerging India Award-2013"

-Acquired Trade Mark and Brand Names Redix Lifecare for a further growth and a wider reach

2014

-Received Kenya (PPB) regulatory and Sri Lanka (CDDA) regulatory approval for Sursez plant.

-Crossed turnover of Rs. 50 Crs

2015

-Awarded with IPE-Business Excellence Awards 2015 in the category of Company of the year "Mid Segment"

2016

-Entered into "Marketing Alliance Agreement" with Astra-IDL Limited to strengthen its mark in generic product segment

-Received IPE-Business Excellence Awards 2016 in the category of Company of the year "Mid Segment" for the consecutive year

2019

-The Company has issued Bonus Shares in the Ratio of 4:10.

-Company 'Received product registration licenses for three products from Turkmenistan''.

-Company received product registration license for one product from Ministry of Health, Cambodia''.Â

2020

-Company Received product registration licenses for two products from Uzbekistan''.

-Received product registration licenses for three products from the Ministry of Health, Cambodia''.

-Zota Health Care Limited announce on 28-Apr-2020, regarding ''Launched new product with the name COROVYL for Viral Infection''.

-Zota Health Care LImited received product registration licenses for two products from Tanzania Medicines and Medical Devices Authority, Tanzania''.Â

2021

-Zota Health Care LImited has informed the Exchange regarding ''Received product registration license for one product from the Ministry of Health, Bolivia''.

-Zota Health Care LImited has informed the Exchange regarding ''Received product registration licenses for two products from the Ministry of Health, Cambodia''.

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article